• The document is a regulatory intimation regarding the availability of the audio recording for the "Q4FY26 and FY2026 Earnings Conference Call."
  • The event type was an earnings conference call discussing Q4 FY2026 and full-year FY2026 financial results.
  • The audio recording has been made available on the company's investor relations website at: https://www.alkemlabs.com/investors/earnings-call.
  • The disclosure is made in compliance with relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • The communication was signed by Manish Narang, President – Legal, Company Secretary & Compliance Officer of Alkem Laboratories Limited.
  • The document was digitally signed on May 28, 2026, at 18:21:18 IST.

Additional Notes Section

  • The document serves as a formal compliance filing submitted to both BSE Limited and National Stock Exchange of India Limited.
  • No financial data, management participants, or specific discussion topics from the earnings call are disclosed in this announcement.
  • The company has fulfilled its regulatory obligation by intimating the availability of the earnings call recording to the stock exchanges.